BioImage, which is based in Copenhagen, Denmark, complements Fisher Biosciences' existing Cellomics business.
The Cellomics platform includes automated imaging instrumentation, BioApplication image analysis software, High Content Informatics software and HitKit® HCS Reagent kits.
The entire Cellomics product portfolio is fully integrated to improve the quality and productivity of high content cell-based assays.
BioImage is a leader in the field of High Content Pathway analysis, providing the life-science market with products, services and licenses that are based on its Redistribution® technology.
Redistribution is a patented technology that monitors protein translocation within a cell and is the basis for many of today's high content assays.
"The addition of BioImage further enhances our portfolio of high content cell-based assays and reagents," said Ron Lowy, president and chief executive officer of Fisher Biosciences.
"Adding BioImage's Redistribution IP, assays, cell-lines and services to our already strong offering of high content screening instrumentation, software, siRNA and assay reagent kits, provides a more complete range of options to customers and strengthens Fisher's leadership position in high content screening."
Fisher will continue operations in Copenhagen.